Effect of oat-containing biscuit on sugar metabolism

ISRCTN ISRCTN10440291
DOI https://doi.org/10.1186/ISRCTN10440291
Submission date
20/09/2023
Registration date
07/11/2023
Last edited
06/11/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Oat is believed to provide health benefits. This study will examine how the ingestion of biscuits, containing beta-glycan fibers from oats, affects blood sugar by using a standard finger prick test for blood sugar.

Who can participate?
Healthy female volunteers aged between 20 and 40 years old

What does the study involve?
After oral intake of a beta-glycan-containing biscuit participants will be subjected to an oral glucose tolerance test (OGTT). The test involves the collection of capillary blood at regular intervals for 2 hours. After around one week the OGTT will be repeated, this time without intake of a biscuit. Testing will take a total of around 3 hours each time.

What are the possible benefits and risks of participating?
The participants will contribute to advanced research on metabolic regulation and this can be of future help for persons affected by diabetes. The risk from participation is negligible. The oat-containing biscuit is a normal nutrient and is not expected to cause any harm. The testing procedure involves blood sampling which can cause minor discomfort.

Where is the study run from?
The study will be run in Singapore by Temasek Polytechnic’s Glycemic Index Research Unit

When is the study starting and how long is it expected to run for?
December 2020 to December 2023

Who is funding the study?
Enterprise Singapore (Singapore)

Who is the main contact?
gunnar.norstedt@ki.se (Sweden)

Contact information

Prof Gunnar Norstedt
Principal Investigator

Karolinska Institute
Forfattarvagen 46
Bromma
16775
Sweden

Phone +46704848548
Email gunnar.norstedt@ki.se
Dr Kalpana Bhaskaran
Scientific

Glycemic Index Research Unit
Temasek Analytical Services Facility
East Wing Block 1A-01-83
21 Tampines Avenue 1
Tampines
529757
Singapore

Phone +65 6780 1849
Email Kalpana_bhaskaran@tp.edu.sg
Mr Micael Györei
Public

Gloobe PTE LTD
Farrer Road
Waterfall Gardens 08-05
-
268822
Singapore

Phone None provided
Email micael@gloobe.se

Study information

Study designNon-randomized cross-over study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital, Pharmaceutical testing facility
Study typePrevention, Efficacy
Participant information sheet 44299_PIS_v1.2_26Jan2021.pdf
Scientific titleEffect of beta glycan-containing biscuits on the Oral Glucose Tolerance Test
Study objectivesBeta glycan may change oral glucose tolerance tests by reducing peak values
Ethics approval(s)

Approved 20/08/2021, Temasek Polytechnic Institutional Review Board (School of Applied Science, Temasek Polytechnic, East Wing Blck 1A, 21 Tampines Ave 1, Tampines, 529765, Singapore; +65 6780-5322; irb@tp.edu.eg), ref: IRB210702

Health condition(s) or problem(s) studiedSugar metabolism in healthy volunteers
InterventionHealthy volunteers will be asked to come fasted to the clinic. Then they will be subjected to a routine oral glucose tolerance test (OGTT) using fingerprick blood sampling with and without prior ingestion of a biscuit containing oat beta-glucan.


On day 0, One biscuit containing beta glycan derived from oats will given before the OGTT. A week later the same individual will be subjected to another OGTT this time without prior ingestion of the biscuit.
Intervention typeSupplement
Primary outcome measureCapillary blood sugar measured using the oral glucose tolerance test on days 0 and 7
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date01/12/2020
Completion date01/12/2023

Eligibility

Participant type(s)Healthy volunteer, Learner/student
Age groupAdult
Lower age limit20 Years
Upper age limit40 Years
SexFemale
Target number of participants30
Total final enrolment30
Key inclusion criteria1. Females
2. Not pregnant
3. No medical condition
4. Age between 20-40 years old
Key exclusion criteriaAny known medical condition
Date of first enrolment01/06/2023
Date of final enrolment01/06/2023

Locations

Countries of recruitment

  • Singapore

Study participating centre

National University Hospital Singapore
5 Lower Kent Ridge rd
Singapore
119074
Singapore

Sponsor information

Temasec Polytechnic
Research organisation

21 Tampines Ave 1
Singapore
529757
Singapore

Phone +65678820000
Email kalpana_bhaskaran@tp-edu.sg
Website https://www.tp.edu.sg/

Funders

Funder type

Government

Enterprise Singapore

No information available

Results and Publications

Intention to publish date01/11/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in non-publicly available repository
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study will be stored in a non-publically available repository. The type of data stored is the result of oral glucose tolerance tests, age and gender. Data files can only be requested by contacting our public contact Micael Györei, micael@gloobe.se. The timing for availability is from December 12, 2023. Participant consent is required and was obtained
Anonymised data will be stored.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version 1.2 26/01/2021 06/11/2023 No Yes

Additional files

44299_PIS_v1.2_26Jan2021.pdf

Editorial Notes

06/11/2023: Study's existence confirmed by the Temasek Polytechnic Institutional Review Board (Singapore).